MYFORTIC 500mg, containing Mycophenolate Mofetil, is an immunosuppressive medication primarily used to prevent organ rejection in transplant patients. This medication works by inhibiting the proliferation of lymphocytes, which are a type of white blood cell involved in the immune response.
MYFORTIC is prescribed to patients who have undergone kidney, heart, or liver transplants. It helps to reduce the risk of rejection by suppressing the immune system's response to the new organ.
Mycophenolate Mofetil inhibits an enzyme necessary for the synthesis of purines, which are essential for lymphocyte proliferation. By limiting the growth of these cells, MYFORTIC effectively reduces the likelihood of organ rejection.
Common side effects of MYFORTIC may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Other potential side effects can include increased risk of infections, changes in blood cell counts, and liver function abnormalities. Always consult your healthcare provider for a complete list of side effects.
MYFORTIC is typically taken orally, with or without food, as directed by your healthcare provider. It is important to follow the prescribed dosage and schedule to ensure the medication's effectiveness.
Before starting MYFORTIC, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Regular monitoring may be necessary to check for side effects and ensure safe use.
MYFORTIC may pose risks during pregnancy and breastfeeding. It is crucial to discuss potential risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
For more information about MYFORTIC, including detailed prescribing information, consult your healthcare provider or visit the official website of the manufacturer.